{"id":90091,"date":"2019-04-29T10:23:02","date_gmt":"2019-04-29T17:23:02","guid":{"rendered":"https:\/\/lifeboat.com\/blog\/2019\/04\/its-the-next-rising-platform-2-promising-technologies-backed-by-billion-dollar-drugmakers-could-transform-the-human-body-into-a-disease-destroying-machine"},"modified":"2019-04-29T10:23:02","modified_gmt":"2019-04-29T17:23:02","slug":"its-the-next-rising-platform-2-promising-technologies-backed-by-billion-dollar-drugmakers-could-transform-the-human-body-into-a-disease-destroying-machine","status":"publish","type":"post","link":"https:\/\/lifeboat.com\/blog\/2019\/04\/its-the-next-rising-platform-2-promising-technologies-backed-by-billion-dollar-drugmakers-could-transform-the-human-body-into-a-disease-destroying-machine","title":{"rendered":"\u2018It\u2019s the next rising platform\u2019: 2 promising technologies backed by billion-dollar drugmakers could transform the human body into a disease-destroying machine"},"content":{"rendered":"<p><a class=\"aligncenter blog-photo\" href=\"https:\/\/lifeboat.com\/blog.images\/its-the-next-rising-platform-2-promising-technologies-backed-by-billion-dollar-drugmakers-could-transform-the-human-body-into-a-disease-destroying-machine.jpg\"><\/a><\/p>\n<p>MeiraGTx\u2019s founders were interested in those uses; the biotech\u2019s programs today are in <a href=https:\/\/www.businessinsider.com\/gene-and-cell-therapy-companies-manufacturing-problems-delays-2019-4 > diseases of the eye, salivary gland and brain.<\/a><\/p>\n<p>But \u201cwe wanted to have a broader perspective on how you could potentially use gene therapy\u201d too, CEO Alexandria Forbes says.<\/p>\n<p>That vision is a high-tech, futuristic one, in which the human body can essentially become a medicine-making factory, enabled by gene therapy. But it\u2019ll require more research, and is still years from fruition.<\/p>\n<p><a href=\"https:\/\/www.businessinsider.com\/new-medicine-tech-backed-by-novartis-johnson-and-johnson-has-big-potential-2019-4\" target=\"_blank\" rel=\"noopener noreferrer\"><\/p>\n<div style=\"clear:both;\">Read more<\/div>\n<p><\/a><\/p>\n","protected":false},"excerpt":{"rendered":"<p>MeiraGTx\u2019s founders were interested in those uses; the biotech\u2019s programs today are in diseases of the eye, salivary gland and brain. But \u201cwe wanted to have a broader perspective on how you could potentially use gene therapy\u201d too, CEO Alexandria Forbes says. That vision is a high-tech, futuristic one, in which the human body can [\u2026]<\/p>\n","protected":false},"author":396,"featured_media":0,"comment_status":"open","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[11,47],"tags":[],"class_list":["post-90091","post","type-post","status-publish","format-standard","hentry","category-biotech-medical","category-neuroscience"],"_links":{"self":[{"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/posts\/90091","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/users\/396"}],"replies":[{"embeddable":true,"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/comments?post=90091"}],"version-history":[{"count":0,"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/posts\/90091\/revisions"}],"wp:attachment":[{"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/media?parent=90091"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/categories?post=90091"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/tags?post=90091"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}